Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Jul. 29, 2023	Jul. 30, 2022
Cash flows from operating activities:
Net income	$ 2,816,149	$ 1,812,335
Adjustments to reconcile net income to net cash provided by operations:
Depreciation	251,785	212,635
Amortization of intangibles	1,505,201	1,512,250
Cost of goods sold for inventory acquired	0	271,396
Stock-based compensation expense	227,113	242,809
Non-cash impairment charge	0	91,953
Gain on sale of property, plant and equipment	0	(4,352)
Deferred income taxes	(431,393)	(205,128)
Operating lease assets and liabilities	4,945	(17,958)
Other	14,185	(7,061)
Changes in operating assets and liabilities	(757,645)	(582,813)
Total adjustments	814,191	1,513,731
Net cash provided by operating activities	3,630,340	3,326,066
Cash flows from investing activities:
Additions to property, plant and equipment	(785,070)	(394,796)
Other	(2,254)	43,761
Net cash used for investing activities	(787,324)	(351,035)
Cash flows from financing activities:
Proceeds from revolver	0	400,000
Payments on revolver	0	(400,000)
Early termination of debt	(65,688)	(519,116)
Proceeds from commercial paper notes	2,646,509	0
Payments of commercial paper notes	(2,101,799)	0
Repurchase of common stock	(2,494,018)	(1,758,832)
Dividend payments to shareholders	(1,251,121)	(1,154,207)
Proceeds from employee stock plans	113,002	30,013
Other	(11,227)	(1,718)
Net cash used for financing activities	(3,164,342)	(3,403,860)
Effect of exchange rate changes on cash	0	(24,175)
Net decrease in cash and cash equivalents	(321,326)	(453,004)
Cash and cash equivalents at beginning of period	1,470,572	1,977,964
Cash and cash equivalents at end of period	$ 1,149,246	$ 1,524,960